A recurrent chalazion that becomes yellowish with surrounding madarosis raises concern for which ocular malignancy?

A recurrent chalazion that becomes yellowish with surrounding madarosis raises concern for which ocular malignancy?

• A. Sebaceous gland carcinoma
• B. Basal cell carcinoma
• C. Squamous cell carcinoma
• D. Malignant melanoma

Answer: (A)

Recognizing a malignant eyelid tumor masquerading as a chalazion is the key idea here. When a chalazion recurs after treatment and the lesion becomes yellowish with surrounding madarosis, suspicion for sebaceous gland carcinoma rises. This cancer arises from the lipid-producing meibomian glands or Zeis glands and often mimics a benign chalazion, but it tends to persist or recur, can appear oily or yellow due to lipid-rich tumor content, and may cause loss or destruction of eyelashes (madarosis) and lid margin irregularity as it invades adnexal structures. Because early detection is crucial for prognosis, such a presentation warrants prompt biopsy and definitive management rather than repeated routine chalazion care. Other eyelid cancers have different hallmark features (for example, basal cell carcinoma typically shows a pearly, telangiectatic lesion; squamous cell carcinoma tends to be an ulcerative or crusted mass; malignant melanoma is usually pigmented and rapidly changing), so the combination of recurrent chalazion with yellow hue and madarosis most strongly points to sebaceous gland carcinoma.

Recognizing a malignant eyelid tumor masquerading as a chalazion is the key idea here. When a chalazion recurs after treatment and the lesion becomes yellowish with surrounding madarosis, suspicion for sebaceous gland carcinoma rises. This cancer arises from the lipid-producing meibomian glands or Zeis glands and often mimics a benign chalazion, but it tends to persist or recur, can appear oily or yellow due to lipid-rich tumor content, and may cause loss or destruction of eyelashes (madarosis) and lid margin irregularity as it invades adnexal structures. Because early detection is crucial for prognosis, such a presentation warrants prompt biopsy and definitive management rather than repeated routine chalazion care. Other eyelid cancers have different hallmark features (for example, basal cell carcinoma typically shows a pearly, telangiectatic lesion; squamous cell carcinoma tends to be an ulcerative or crusted mass; malignant melanoma is usually pigmented and rapidly changing), so the combination of recurrent chalazion with yellow hue and madarosis most strongly points to sebaceous gland carcinoma.